Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

Some of the neurological symptoms associated with menopause are similar to early signs of dementia. The ability of MHT to alleviate such symptoms in some women has led scientists to question whether a link exists between specific hormone levels and dementia.

The US Food and Drug Administration on Thursday said it has granted Emergency Use Authorization for Detect's over-the-counter, at-home SARS-CoV-2 test.

A few days ago, EUROIMMUN (PerkinElmer) formally completed the acquisition of British diagnostic company Immunodiagnostic Systems (IDS). In the future, IDS, as a new member of the PerkinElmer Group, will cooperate closely with EUROIMMUN in the fields of R&D, production, and sales.

CareDx reported after the close of the market on Thursday that its third quarter revenues rose 42 percent year over year, thanks largely to a 46 percent increase in testing service revenues during the quarter.

A newly developed coating that allows for certain liquids to move across surfaces without fluid loss could usher in new advances in a range of fields including medical testing.

Thermo Fisher Scientific reported before the opening of the market on Wednesday that its third quarter revenues rose 9 percent year over year, thanks to growth across three of its four business segments.

Researchers from Newcastle University, and colleagues from Spain, Canada and Egypt, have successfully trialled two new qPCR assays to help detect the presence of transmissible AMR using water and wastewater samples.

GenomSys said Wednesday that it has received CE marking for the GenomSys Variant Analyzer.

Autobio Diagnostics Co., Ltd (603658.SH) released the third quarter report：the first three quarters of this year's total sale is CNY 2.695 billion, up 31.64% year on year. Net profit attributable to shareholders of listed companies reached was CNY 717 million, up 39.33% year-on-year.

The US Food and Drug Administration last week granted Emergency Use Authorization for InBios International's SCoV-2 Detect Neutralizing Ab ELISA immunoassay for SARS-CoV-2.